Bloomberg Originals
Bloomberg Originals
@business·5.1M subscribers·49.5K videos

Why Vaccine Challenge Trials Are So Controversial

Posted

April 16, 2021

Views

38,295

Likes

716

Comments

87

Engagement

2.10%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Is it ethical, or even possible, that deliberately exposing healthy volunteers to harmful pathogens would mean faster vaccine research for everyone? That's the question being considered by both sides of the debate over human challenge trials, one of the most hotly contested topics in medicine today, thanks to the Covid-19 pandemic.

#Covid19 #Prognosis #Medicine

--------

Like this video? Subscribe

Become a Quicktake Member for exclusive perks

QuickTake Originals is Bloomberg's official premium video channel. We bring you insights and analysis from business, science, and technology experts who are shaping our future. We’re home to Hello World, Giant Leap, Storylines, and the series powering CityLab, Bloomberg Businessweek, Bloomberg Green, and much more.

Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.

Visit our partner channel QuickTake News for breaking global news and insight in an instant.

Guests & Subjects Covered

Covid Prognosis MedicineSubscribe BecomeQuicktake MemberQuickTake OriginalsQuickTake News

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Why Vaccine Challenge Trials Are So Controversial · Bloomberg Originals · Sentinel